CompaniesUpjohn

Upjohn

defunct
About

Defunct Company

Areas of Focus

Categories

MergedBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (9)
View all

Total Trials

9

As Lead Sponsor

0

As Collaborator

9

Total Enrollment

293

By Phase

PHASE3: 2PHASE2: 3NA: 1PHASE1: 3

By Status

COMPLETED: 8WITHDRAWN: 1

Recent Trials

NCT00006083Collaborator
Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter
PHASE3Completed
Started: Apr 30, 2000 · Completed: Nov 30, 2000
NCT00005626Collaborator
Phase II Trial With Correlative Laboratory Studies of Single Agent Irinotecan (Camptosar CPT-11)
PHASE2Completed
10 participants
Started: Feb 28, 1998 · Completed: Nov 30, 2003
NCT00000674Collaborator
A Pilot Study of Oral Clindamycin and Pyrimethamine for the Treatment of Toxoplasmic Encephalitis in Patients With AIDS
NACompleted
30 participants
NCT00000741Collaborator
The Safety and Effectiveness of Methylprednisolone in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Children With AIDS
PHASE3Withdrawn
NCT00000742Collaborator
A Phase I Concentration-Controlled Trial to Assess the Safety, Tolerance, Pharmacokinetics and Development of Decreased HIV-1 Susceptibility to the Combination of Atevirdine Mesylate (U-87201E), Zidovudine (AZT), and Didanosine (ddI)
PHASE1Completed
15 participants
View all 9 trials →
Funding History (4)
8-K
Nov 9, 1995
Filing
8-K
Aug 21, 1995
Filing
DEF 14A
Mar 24, 1995
Filing
DEF 14A
Apr 11, 1994
Filing
Related Companies
Pharmacia In 1995 To Become Pharmacia & Upjohn----------------------------------------if You Believe Any Of This Information Is Incorrect
merged